Futura Medical (GB:FUM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Futura Medical plc has announced a milestone payment of $5.0m from Haleon following the successful US launch and distribution of Eroxon®, their innovative over-the-counter erectile dysfunction gel. The payment was triggered by pre-orders and retail availability in the US, signifying strong market reception for Eroxon®, which offers a fast-acting solution for men with ED. This marks a significant step for Futura in capitalizing on the ED market, with Eroxon® having received industry acclaim and awards.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
